1. Home
  2. BODI vs RNAZ Comparison

BODI vs RNAZ Comparison

Compare BODI & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

N/A

Current Price

$4.27

Market Cap

30.3M

Sector

Industrials

ML Signal

N/A

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$1.55

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BODI
RNAZ
Founded
1998
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
27.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BODI
RNAZ
Price
$4.27
$1.55
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $16.25
N/A
AVG Volume (30 Days)
11.3K
★ 29.4K
Earning Date
11-10-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 96.10
N/A
EPS
★ 0.47
N/A
Revenue
★ $251,727,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.09
N/A
P/E Ratio
$9.10
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.01
$1.52
52 Week High
$16.87
$12.60

Technical Indicators

Market Signals
Indicator
BODI
RNAZ
Relative Strength Index (RSI) 40.46 38.38
Support Level $4.01 $1.57
Resistance Level $5.11 $1.95
Average True Range (ATR) 0.23 0.15
MACD 0.05 0.02
Stochastic Oscillator 47.22 11.45

Price Performance

Historical Comparison
BODI
RNAZ

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: